A detailed history of Avantax Advisory Services, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 27,130 shares of ZTS stock, worth $4.79 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
27,130
Previous 31,775 14.62%
Holding current value
$4.79 Million
Previous $5.51 Million 3.78%
% of portfolio
0.04%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$172.58 - $196.48 $801,634 - $912,649
-4,645 Reduced 14.62%
27,130 $5.3 Million
Q2 2024

Aug 09, 2024

BUY
$145.54 - $178.83 $3.14 Million - $3.85 Million
21,552 Added 210.82%
31,775 $5.51 Million
Q1 2024

May 08, 2024

BUY
$165.67 - $199.94 $98,739 - $119,164
596 Added 6.19%
10,223 $1.73 Million
Q4 2023

Feb 07, 2024

BUY
$151.44 - $200.09 $100,253 - $132,459
662 Added 7.38%
9,627 $1.9 Million
Q3 2023

Nov 07, 2023

BUY
$167.14 - $192.77 $127,527 - $147,083
763 Added 9.3%
8,965 $1.56 Million
Q2 2023

Aug 11, 2023

BUY
$160.94 - $186.23 $32,831 - $37,990
204 Added 2.55%
8,202 $1.41 Million
Q1 2023

Apr 28, 2023

BUY
$145.48 - $175.02 $191,888 - $230,851
1,319 Added 19.75%
7,998 $1.33 Million
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $292,573 - $351,315
2,231 Added 50.16%
6,679 $979,000
Q3 2022

Nov 01, 2022

BUY
$148.29 - $182.55 $26,543 - $32,676
179 Added 4.19%
4,448 $660,000
Q2 2022

Aug 02, 2022

SELL
$155.97 - $200.09 $73,773 - $94,642
-473 Reduced 9.97%
4,269 $734,000
Q1 2022

Apr 27, 2022

SELL
$181.39 - $234.03 $99,583 - $128,482
-549 Reduced 10.38%
4,742 $897,000
Q4 2021

Jan 24, 2022

BUY
$193.69 - $247.03 $45,710 - $58,299
236 Added 4.67%
5,291 $1.29 Million
Q3 2021

Oct 21, 2021

BUY
$189.29 - $209.69 $116,791 - $129,378
617 Added 13.9%
5,055 $981,000
Q2 2021

Jul 29, 2021

SELL
$155.9 - $187.99 $41,313 - $49,817
-265 Reduced 5.63%
4,438 $828,000
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $207,072 - $243,582
1,438 Added 44.04%
4,703 $746,000
Q4 2020

Jan 22, 2021

SELL
$157.07 - $174.35 $1.17 Million - $1.3 Million
-7,461 Reduced 69.56%
3,265 $537,000
Q3 2020

Oct 14, 2020

BUY
$137.1 - $165.37 $1.09 Million - $1.31 Million
7,921 Added 282.39%
10,726 $1.77 Million
Q2 2020

Aug 06, 2020

BUY
$111.92 - $142.53 $44,208 - $56,299
395 Added 16.39%
2,805 $383,000
Q1 2020

Apr 30, 2020

BUY
$92.66 - $144.94 $36,786 - $57,541
397 Added 19.72%
2,410 $283,000
Q4 2019

Feb 14, 2020

BUY
$116.25 - $133.25 $234,011 - $268,232
2,013 New
2,013 $267,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.